Clinical Trial Update: Clinical Evaluation of Two Marketed Artificial Tears in Non-contact Lens Wearing Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating two marketed artificial tears in non-contact lens wearers; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visual Acuity

Drugs mentioned

• Two marketed artificial tears

Snippet

Sponsor: Johnson & Johnson Vision Care, Inc. | Conditions: Visual Acuity | Phase 4 | Status: COMPLETED | Results posted: 2019-05-29